Indeed, preclinical studies using bladder cancer cell models or xenografted mice demonstrated that inhibition of mTOR by everolimus inhibited bladder cancer cell growth in vitro and in xenografted mice [19]. Here, MTOR is linked to urinary bladder carcinoma.